SHANGHAI RIGHTONGENE BIOTECHNOLOGY financial statements, including revenue, expenses, profit, and loss
The total revenue of 688217 for the last quarter is 58.75 M CNY, and it's 16.85% lower compared to the previous quarter. The net income of Q4 23 is -10.90 M CNY.